We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues 'Favorable' Inspection Results to Chiron, But More Work Needed
FDA Issues 'Favorable' Inspection Results to Chiron, But More Work Needed
August 31, 2005
Chiron has made significant strides to bring its Liverpool, England, manufacturing plant into compliance with U.S. standards, but the embattled vaccine manufacturer still needs to make additional improvements before it can return its influenza vaccine, Fluvirin, to the U.S. market, the FDA said.